Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zoran Hasanbasic"'
Autor:
Ursula Schmidt-Ott, Scott Fitzpatrick, Zoran Hasanbasic, Sergio Leal, Peter Morgan-Warren, Xin Zhang, Kristian T Johnson
Publikováno v:
Clinical Ophthalmology.
Ursula Schmidt-Ott,1 Scott Fitzpatrick,2 Zoran Hasanbasic,3 Sergio Leal,3 Peter Morgan-Warren,4 Xin Zhang,3 Kristian T Johnson5 1Bayer AG, Berlin, Germany; 2Bayer AG, Mississauga, Canada; 3Bayer Consumer Care AG, Basel, Switzerland; 4Bayer PLC, Readi
Autor:
Peter Wiedemann, Joachim Wachtlin, Nicole Eter, Georgios Keramas, Christine Rech, Helmut G. Sachs, Carsten Framme, Zoran Hasanbasic, Harald Schilling
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology
Purpose To investigate the influence of treatment regularity with intravitreal aflibercept injections (IVT-AFL injections) on visual acuity (VA) outcomes in patients with neovascular age-related macular degeneration (nAMD) enrolled in the PERSEUS tri
Autor:
Harald Schilling, Helmut G. Sachs, Carsten Framme, Peter Wiedemann, Joachim Wachtlin, Georgios Keramas, Zoran Hasanbasic, Nicole Eter, Christine Rech
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology
Purpose To evaluate the real-world effectiveness of intravitreal aflibercept injections in Germany in patients with neovascular age-related macular degeneration over 24 months. Methods PERSEUS was a prospective, non-interventional cohort study. The p
Autor:
Zoran Hasanbasic, Christoph Ehlken, Hansjürgen Agostini, Sabrina Müller, Ulrike Bauer-Steinhusen, Thomas Wilke
Publikováno v:
Retina. 38:1134-1144
The PONS study was conceived to analyze the extent of nonpersistence (NP) and nonadherence (NA) in the treatment of patients with neovascular age-related macular degeneration in everyday clinical practice in Germany. Further objectives were to identi
Autor:
Helmut G. Sachs, Nicole Eter, Carsten Framme, Harald Schilling, Joachim Wachtlin, Ulrich Thelen, Miriam Kahl, Thomas Hamacher, Peter Wiedemann, Zoran Hasanbasic, K. T. M. Johnson, Claudia Jochmann
Publikováno v:
Ophthalmology Retina. 2:539-549
Purpose To explore real-world effectiveness of intravitreal aflibercept injection (IAI) for neovascular age-related macular degeneration (nAMD) in Germany. Design A 24-month, prospective, noninterventional, noncontrolled, multicenter observational co
Autor:
Hansjürgen Agostini, Christoph Ehlken, Ulrike Bauer-Steinhusen, Zoran Hasanbasic, Thomas Wilke, Sabrina Mueller
Publikováno v:
Ophthalmology. 123:876-883
Purpose The objective of our study was to investigate preferences of patients with neovascular age-related macular degeneration (nAMD) for different anti-vascular endothelial growth factor (VEGF) treatment schemes. Design We used a discrete choice ex
Autor:
Carsten, Framme, Nicole, Eter, Thomas, Hamacher, Zoran, Hasanbasic, Claudia, Jochmann, Kristian T, Johnson, Miriam, Kahl, Helmut, Sachs, Harald, Schilling, Ulrich, Thelen, Peter, Wiedemann, Joachim, Wachtlin
Publikováno v:
Ophthalmology. Retina. 2(6)
To explore real-world effectiveness of intravitreal aflibercept injection (IAI) for neovascular age-related macular degeneration (nAMD) in Germany.A 24-month, prospective, noninterventional, noncontrolled, multicenter observational cohort study.Patie
Autor:
Zoran Hasanbasic, Ulrike Bauer-Steinhusen, Hansjürgen Agostini, Thomas Wilke, Sabrina Müller, Christoph Ehlken
Publikováno v:
Ophthalmology. 123(4)
The objective of our study was to investigate preferences of patients with neovascular age-related macular degeneration (nAMD) for different anti-vascular endothelial growth factor (VEGF) treatment schemes.We used a discrete choice experiment (DCE) d